plumbagin has been researched along with Shock, Septic in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Checker, R; Menon, J; Patwardhan, RS; Poduval, TB; Sainis, KB; Sandur, SK; Sharma, D; Thoh, M | 1 |
1 other study(ies) available for plumbagin and Shock, Septic
Article | Year |
---|---|
Plumbagin, a vitamin K3 analogue, abrogates lipopolysaccharide-induced oxidative stress, inflammation and endotoxic shock via NF-κB suppression.
Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Cell Line; Dinoprostone; Disease Models, Animal; Dose-Response Relationship, Drug; Down-Regulation; Enzyme Activation; Extracellular Signal-Regulated MAP Kinases; Inflammation Mediators; Interleukin-6; Lipopolysaccharides; Liver; Lung; Macrophages; Male; Mice; Naphthoquinones; NF-kappa B; Nitric Oxide; Oxidative Stress; Shock, Septic; Signal Transduction; Spleen; Time Factors; Tumor Necrosis Factor-alpha | 2014 |